Biomarin Pharmaceutical (BMRN) FCF Margin (2009 - 2026)
Biomarin Pharmaceutical's FCF Margin came in at 14.07% for Q2 2026, down 6.30 percentage points from 20.37% a year earlier and down 11.99 percentage points from the prior quarter.
Biomarin Pharmaceutical (BMRN) FCF Margin (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Biomarin Pharmaceutical reported FCF Margin of 21.67%, down 1.01 percentage points year-over-year; for FY2025, it came in at 22.51%, up 5.43 percentage points from FY2024.
- FCF Margin carries a five-year change of +24.06 percentage points (FY2020 to FY2025).
- Going back by year, FCF Margin was 17.08% in FY2024 (+14.49 pp), 2.59% in FY2023 (-0.03 pp), 2.62% in FY2022 (-8.70 pp) and 11.32% in FY2021 (+12.87 pp).
- The five-year range for quarterly FCF Margin is -16.50% (Q1 2023) to 43.84% (Q3 2025).
- Year-over-year, FCF Margin increased in six of the last eight quarters, with an average year-over-year change of +6.81 percentage points.
- The fastest year-over-year change in FCF Margin over five years came in Q4 2024 (a gain of 22.45 percentage points), and the weakest in Q1 2022 (a drop of 32.40 percentage points).
- Business Quant data shows BMRN's FCF Margin at 26.07% (Q1 2026), 6.74% (Q4 2025) and 43.84% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Biomarin Pharmaceutical | 11.51 Bn | 5.37 Bn | 786.91 Mn | 14.07% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.07% |
| Mar 31, 2026 | 26.07% |
| Dec 31, 2025 | 6.74% |
| Sep 30, 2025 | 43.84% |
| Jun 30, 2025 | 20.37% |
| Mar 31, 2025 | 21.15% |
| Dec 31, 2024 | 22.23% |
| Sep 30, 2024 | 27.22% |
| Jun 30, 2024 | 13.68% |
| Mar 31, 2024 | 3.22% |
| Dec 31, 2023 | -0.22% |
| Sep 30, 2023 | 19.59% |
| Jun 30, 2023 | 8.14% |
| Mar 31, 2023 | -16.50% |
| Dec 31, 2022 | -5.38% |
| Sep 30, 2022 | 25.53% |
| Jun 30, 2022 | 5.45% |
| Mar 31, 2022 | -14.30% |
| Dec 31, 2021 | -3.90% |
| Sep 30, 2021 | 19.16% |
Biomarin Pharmaceutical FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=BMRN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();